Medication info
Pelojeong 5 mg (Memantine Hydrochloride)

Pelojeong 5 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›5mg / 1 tablet
Manufacturer / importer
Myeongin Pharmaceutical Co., Ltd.
Appearance
Pale yellow round film-coated tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 202003712 · Approved 2020.05.21 · Insurance code 651904960

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is able to regularly monitor the patient's medication use. Diagnosis should be made in accordance with currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7) Administer 5mg daily for 7 days. Week 2 (days 8-14) Administer 10mg daily for 7 days. Week 3 (days 15-21) Administer 15mg daily for 7 days. Starting week 4 Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose titration schedule after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Myeongin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps alleviate symptoms related to cognitive decline in patients, thereby easing difficulties in daily life. With consistent use, it can delay the deterioration of memory and cognitive abilities. This drug contributes to improving the quality of life for patients and their families. Because of these characteristics, it is recommended as a suitable treatment for patients with severe Alzheimer's.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is able to regularly monitor the patient's medication use. Diagnosis should be made in accordance with currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7) Administer 5mg daily for 7 days. Week 2 (days 8-14) Administer 10mg daily for 7 days. Week 3 (days 15-21) Administer 15mg daily for 7 days. Starting week 4 Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose titration schedule after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be administered to patients who have had an allergic reaction to any of its components. It should also be avoided in patients with severely impaired liver function or very poor kidney function. Additionally, this medication contains lactose, so individuals with a genetic disorder that prevents them from digesting lactose should not take it. Patients with epilepsy or a history of seizures should use this medication cautiously, as side effects may worsen when taken with certain drugs. Patients with changes in urine acidity or recent heart-related disorders should also exercise caution when using this medication. During use, symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur; thus, if any abnormal symptoms appear, consult a physician. This medication may interact with other drugs, particularly those affecting the central nervous system, so it is essential to follow a specialist's guidance when taking them together. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, and it is advisable to discontinue breastfeeding if possible. It is preferable not to use this medication in children or adolescents under 18 years of age, as safety and efficacy have not been established. In cases of overdose, central nervous system symptoms or digestive symptoms may appear; immediate medical attention is required in such cases. This medication may decrease the patient's reaction speed and concentration, so caution is advised when driving or operating machinery. Finally, store this medication out of reach of children and do not transfer it to another container for safety.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 22 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • abnormal comatose state
  • double vision
  • agitation
  • restlessness
  • psychosis
  • visual hallucinations
  • confusion
  • unconsciousness
  • tiredness
  • weakness
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container that prevents air and moisture from entering, at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.